FeesSafety
Pluang+

HNI reports Q3 2026 EPS up 47% on Steelcase acquisition and strong sales growth

Company Fundamentals
03 Nov 2026, 14:30 WIB
GlobeNewsWire
View Source
Bullish
HNI reports Q3 2026 EPS up 47% on Steelcase acquisition and strong sales growth

HNI Corporation posted strong Q3 2026 results with GAAP diluted EPS of $1.23 (+39.8% YoY) and non-GAAP EPS of $1.62 (+47.3% YoY), driven by the Steelcase acquisition, operational efficiencies, and organic sales growth. Net sales rose 133% to $1.6 billion, including $870.6 million from Steelcase, with organic sales up 5.6%. Both Workplace Furnishings and Residential Building Products segments showed volume growth and margin expansion despite macroeconomic challenges. The company expects continued double-digit EPS growth in 2026 and beyond, supported by cost management, synergy realization, and manufacturing optimization.

HNI Corporation's Q3 2026 results provide context for industrial sector performance. For readers following Industrials, here is Pluang's market snapshot as of Nov 03, 2026 18:42 WIB: Among 135 priced US Industrials stocks, 73 rose and 53 fell today. Star Bulk Carriers Corp (SBLK) gained 2.29% to USD 27.73 with a typical hold time of 28 days, contrasting with BWX Technologies (BWXT) which dropped 2.07% to USD 127.77 and MasTec Inc (MTZ) rising 2.18% to USD 198.00 despite 100% sell order activity, held typically for 29 days.

More News

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...

Market News
Bullish
21 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
3 hours ago
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
3 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
3 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App